The SJSA-1 osteosarcoma cell line, containing wild-type p53 and an amplified MDM2 gene, is sensitive to MDM2 inhibitors and has been used extensively as a model with which to investigate the efficacy and mechanism of action for different classes of MDM2 inhibitors. The gene discussed is TP53; the disease is osteosarcoma.